Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

Imagabalin

Index Imagabalin

Imagabalin (INN, USAN; PD-332,334) is a drug which acts as a ligand for the α2δ subunit of the voltage-dependent calcium channel, with some selectivity for the α2δ1 subunit over α2δ2. [1]

22 relations: Analgesic, Anticonvulsant, Anxiolytic, Atagabalin, Binding selectivity, CACNA2D1, CACNA2D2, Clinical trial, Drug, Gabapentinoid, Generalized anxiety disorder, Hydrochloride, Hypnotic, International nonproprietary name, Ligand, Medication, PD-217,014, Pfizer, Phases of clinical research, Pre-clinical development, United States Adopted Name, Voltage-gated calcium channel.

Analgesic

An analgesic or painkiller is any member of the group of drugs used to achieve analgesia, relief from pain.

New!!: Imagabalin and Analgesic · See more »

Anticonvulsant

Anticonvulsants (also commonly known as antiepileptic drugs or as antiseizure drugs) are a diverse group of pharmacological agents used in the treatment of epileptic seizures.

New!!: Imagabalin and Anticonvulsant · See more »

Anxiolytic

An anxiolytic (also antipanic or antianxiety agent) is a medication or other intervention that inhibits anxiety.

New!!: Imagabalin and Anxiolytic · See more »

Atagabalin

Atagabalin (PD-0200,390) is a drug developed by Pfizer and related to gabapentin, which similarly binds to the α2δ calcium channels (1 and 2).

New!!: Imagabalin and Atagabalin · See more »

Binding selectivity

Binding selectivity is defined with respect to the binding of ligands to a substrate forming a complex.

New!!: Imagabalin and Binding selectivity · See more »

CACNA2D1

Voltage-dependent calcium channel subunit alpha-2/delta-1 is a protein that in humans is encoded by the CACNA2D1 gene.

New!!: Imagabalin and CACNA2D1 · See more »

CACNA2D2

Voltage-dependent calcium channel subunit alpha2delta-2 is a protein that in humans is encoded by the CACNA2D2 gene.

New!!: Imagabalin and CACNA2D2 · See more »

Clinical trial

Clinical trials are experiments or observations done in clinical research.

New!!: Imagabalin and Clinical trial · See more »

Drug

A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body.

New!!: Imagabalin and Drug · See more »

Gabapentinoid

Gabapentinoids, also known as α2δ ligands, are a class of drugs that are derivatives of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) (i.e., GABA analogues) which block α2δ subunit-containing voltage-dependent calcium channels (VDCCs).

New!!: Imagabalin and Gabapentinoid · See more »

Generalized anxiety disorder

Generalized anxiety disorder (GAD) is an anxiety disorder characterized by excessive, uncontrollable and often irrational worry, that is, apprehensive expectation about events or activities.

New!!: Imagabalin and Generalized anxiety disorder · See more »

Hydrochloride

In chemistry, a hydrochloride is an acid salt resulting, or regarded as resulting, from the reaction of hydrochloric acid with an organic base (e.g. an amine).

New!!: Imagabalin and Hydrochloride · See more »

Hypnotic

Hypnotic (from Greek Hypnos, sleep) or soporific drugs, commonly known as sleeping pills, are a class of psychoactive drugs whose primary function is to induce sleep and to be used in the treatment of insomnia (sleeplessness), or surgical anesthesia.

New!!: Imagabalin and Hypnotic · See more »

International nonproprietary name

The International Nonproprietary Name (INN) is an official generic and non-proprietary name given to a pharmaceutical drug or an active ingredient.

New!!: Imagabalin and International nonproprietary name · See more »

Ligand

In coordination chemistry, a ligand is an ion or molecule (functional group) that binds to a central metal atom to form a coordination complex.

New!!: Imagabalin and Ligand · See more »

Medication

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease.

New!!: Imagabalin and Medication · See more »

PD-217,014

PD-217,014 is a drug developed by Pfizer and related to gabapentin, which similarly binds to the α2δ calcium channels (1 and 2).

New!!: Imagabalin and PD-217,014 · See more »

Pfizer

Pfizer Inc. is an American pharmaceutical conglomerate headquartered in New York City, with its research headquarters in Groton, Connecticut.

New!!: Imagabalin and Pfizer · See more »

Phases of clinical research

The phases of clinical research are the steps in which scientists do experiments with a health intervention in an attempt to find enough evidence for a process which would be useful as a medical treatment.

New!!: Imagabalin and Phases of clinical research · See more »

Pre-clinical development

In drug development, preclinical development, also named preclinical studies and nonclinical studies, is a stage of research that begins before clinical trials (testing in humans) can begin, and during which important feasibility, iterative testing and drug safety data are collected.

New!!: Imagabalin and Pre-clinical development · See more »

United States Adopted Name

United States Adopted Names are unique nonproprietary names assigned to pharmaceuticals marketed in the United States.

New!!: Imagabalin and United States Adopted Name · See more »

Voltage-gated calcium channel

Voltage-gated calcium channels (VGCCs), also known as voltage-dependent calcium channels (VDCCs), are a group of voltage-gated ion channels found in the membrane of excitable cells (e.g., muscle, glial cells, neurons, etc.) with a permeability to the calcium ion Ca2+.

New!!: Imagabalin and Voltage-gated calcium channel · See more »

Redirects here:

Imagabalin hydrochloride, PD 0332334, PD 332,334, PD 332334, PD-0332334, PD-332,334, PD-332334.

References

[1] https://en.wikipedia.org/wiki/Imagabalin

OutgoingIncoming
Hey! We are on Facebook now! »